Harnessing the cloud

By Amy Maxmen Harnessing the cloud Free platforms for powering your genomics and proteomics data analysis using processing power rented in the sky No longer must biologists covet the computer clusters of their colleagues. Cloud-computing—computing power accessed over the Internet—lets biologists without their own computer cluster store and analyze floods of data. The main space for rent is on Amazon Web Services (AWS), where, for less than $1 per hour

Written byAmy Maxmen
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

No longer must biologists covet the computer clusters of their colleagues. Cloud-computing—computing power accessed over the Internet—lets biologists without their own computer cluster store and analyze floods of data. The main space for rent is on Amazon Web Services (AWS), where, for less than $1 per hour, researchers can have access to powerful processors only as they need them.

Integrating bioinformatics programs with the cloud requires considerable computer expertise. Luckily, developers are creating free and easy-to-operate platforms for genomics and proteomics. After paying for space on the cloud, researchers can use these programs to analyze data as simply as they’d plan a vacation online.

Cloud-computing is relatively new, therefore the bugs have yet to be realized. Certain developers voice concern about Amazon’s virtual monopoly on rentable cloud space. And as for biologists, the first obstacle may simply be learning which applications suit their needs best.

Hypothetical concerns aside, Deepak Singh, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies